About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Endocrine-Related Cancer
›
Top Articles
Endocrine-Related Cancer
Endocrinology
,
Oncology
5.7
(top 2%)
Impact Factor
6.2
(top 2%)
extended IF
130
(top 2%)
H-Index
2.3K
authors
2.3K
papers
99K
citations
4.7K
citing journals
52K
citing authors
Most Cited Articles of Endocrine-Related Cancer
Title
Year
Citations
Fibroblast growth factors, their receptors and signaling
2000
981
BRAF mutation in thyroid cancer
2005
960
Diabetes and cancer
2009
707
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
2012
550
The role of let-7 in cell differentiation and cancer
2010
509
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
2001
489
Mechanisms of tamoxifen resistance
2004
448
MicroRNA deregulation in human thyroid papillary carcinomas
2006
417
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
2013
403
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
2007
380
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
2005
375
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
2001
352
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
2010
343
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle
2007
341
Resveratrol and cancer: focus on in vivo evidence
2014
332
Discovery of a novel Raf kinase inhibitor
2001
321
Current and emerging biomarkers in breast cancer: prognosis and prediction
2010
320
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
2005
317
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression
2004
313
Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution
2014
302
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
2009
296
Molecular links between obesity and breast cancer
2006
296
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
2010
292
Management of patients with adrenal cancer: recommendations of an international consensus conference
2005
288
Alternatively spliced androgen receptor variants
2011
280
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.